Our attorneys have filed a mass tort lawsuit on behalf of sufferers who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical firms, such as the makers of Xarelto, have a duty to ensure that their drugs are reasonably safe for use – and failure to perform so may possibly be grounds for compensation. Our lawyers are functioning difficult to have those hurt by the drug the compensation they are entitled to.
While bleeding is a typical complication associated with anticoagulants, it has been alleged that Xarelto is much more harmful than classic blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This implies that, in the event of an emergency, patients may be at threat for irreversible bleeding troubles, such as life-threatening internal and gastrointestinal hemorrhaging.
Should you or even a loved one particular suffered a significant bleeding occasion following taking Xarelto, you might have legal recourse. For far more details, get in touch with us nowadays to possess your case reviewed, cost-free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are looking for compensation from Bayer and Janssen for previous and future health-related bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Furthermore, they are seeking punitive damages, which are generally awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Getting Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege significant and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.
Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.
Visit this page for a lot more data on the alleged health risks of when was xarelto put on the market.
Multidistrict Litigation Trial Dates Set
The attorneys inside the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.